Skin, hair and beyond: the impact of menopause.


Journal

Climacteric : the journal of the International Menopause Society
ISSN: 1473-0804
Titre abrégé: Climacteric
Pays: England
ID NLM: 9810959

Informations de publication

Date de publication:
10 2022
Historique:
pubmed: 5 4 2022
medline: 9 9 2022
entrez: 4 4 2022
Statut: ppublish

Résumé

The skin is an endocrine organ and a major target of hormones such as estrogens, androgens and cortisol. Besides vasomotor symptoms (VMS), skin and hair symptoms often receive less attention than other menopausal symptoms despite having a significant negative effect on quality of life. Skin and mucosal menopausal symptoms include dryness and pruritus, thinning and atrophy, wrinkles and sagging, poor wound healing and reduced vascularity, whereas skin premalignant and malignant lesions and skin aging signs are almost exclusively caused by environmental factors, especially solar radiation. Hair menopausal symptoms include reduced hair growth and density on the scalp (diffuse effluvium due to follicular rarefication and/or androgenetic alopecia of female pattern), altered hair quality and structure, and increased unwanted hair growth on facial areas. Hormone replacement therapy (HRT) is not indicated for skin and hair symptoms alone due to the risk-benefit balance, but wider potential benefits of HRT (beyond estrogen's effect on VMS, bone, breast, heart and blood vessels) to include skin, hair and mucosal benefits should be discussed with women so that they will be able to make the best possible informed decisions on how to prevent or manage their menopausal symptoms.

Identifiants

pubmed: 35377827
doi: 10.1080/13697137.2022.2050206
doi:

Substances chimiques

Estrogens 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

434-442

Auteurs

C C Zouboulis (CC)

Departments of Dermatology, Venereology, Allergology and Immunology, Dessau Medical Center, Brandenburg Medical School Theodor Fontane and Faculty of Health Sciences, Brandenburg, Germany.

U Blume-Peytavi (U)

Department of Dermatology, Venerology and Allergology, Charité Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Germany.

M Kosmadaki (M)

Dermoiatriki Athens, Athens, Greece.

E Roó (E)

Clider Clínica Dermatológica Roó, Universidad Francisco de Vitoria, Madrid, Spain.

D Vexiau-Robert (D)

Gynecology, Saint-Louis Hospital, Paris, France.

D Kerob (D)

Laboratoires Vichy, Levallois-Perret, France.

S R Goldstein (SR)

School of Medicine, New York University Grossman, New York, NY, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH